Biomarin ranked the 10th most innovative company in the world
For the third consecutive year, BioMarin earned a Top 10 ranking on Forbes magazine's list of the "World's Most Innovative Companies."
"We are humbled to once again be recognized as a leader in innovation by Forbes. We look forward to continuing to provide underserved patients with treatment options that can make a meaningful difference in their lives."
– Jean-Jacques Bienaimé, Chairman and Chief Executive Officer
For nearly 20 years, BioMarin has been a pioneer in the development of medicine for rare genetic disease. This recognition by Forbes acknowledges the company's ongoing commitment to rapidly developing and delivering first-in-class or best-in-class therapies for those with severe or life-threatening diseases.
Rankings are based on what Forbes calls the companies' "innovation premium," the difference between their market capitalization and a net present value of cash flows from current businesses.
Forbes' method relies on investors' ability to identify companies they expect to be innovative now and in the future. The recognition only includes businesses that have at least seven years of financial data and a market value greater than $10 billion, and have measurable investment in research and development.
To view the complete list, click here.